Thaminda Ramanayake is a venture partner at Entrée Bio at Entrée Capital. He previously held business development and strategy leadership roles at CureVac, Affini-T, Sanofi, BioMarin and Amgen.
Thaminda Ramanayake is a venture partner at Entrée Bio at Entrée Capital. He previously held business development and strategy leadership roles at CureVac, Affini-T, Sanofi, BioMarin and Amgen.
Career
Thaminda Ramanayake holds a BS, Molecular, Cellular and Systems Biology; MS, Immunology; MBA, Finance from University of Rochester.